STERIS plc $STE Shares Sold by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL trimmed its position in STERIS plc (NYSE:STE) by 91.2% during the third quarter, Holdings Channel.com reports. The firm owned 1,807 shares of the medical equipment provider’s stock after selling 18,628 shares during the period. Tudor Investment Corp ET AL’s holdings in STERIS were worth $447,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Jones Financial Companies Lllp grew its stake in STERIS by 46.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider’s stock worth $251,000 after buying an additional 349 shares during the last quarter. Goldman Sachs Group Inc. raised its position in STERIS by 32.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider’s stock worth $55,015,000 after buying an additional 59,264 shares during the last quarter. Empowered Funds LLC lifted its stake in shares of STERIS by 16.1% in the 1st quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider’s stock worth $522,000 after acquiring an additional 319 shares during the period. Woodline Partners LP lifted its stake in shares of STERIS by 40.0% in the 1st quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider’s stock worth $1,881,000 after acquiring an additional 2,372 shares during the period. Finally, Jane Street Group LLC boosted its holdings in shares of STERIS by 38.9% in the first quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider’s stock valued at $4,695,000 after acquiring an additional 5,803 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the firm’s stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the transaction, the director owned 705 shares in the company, valued at approximately $167,233.05. This trade represents a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.07% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on STE. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Wall Street Zen lowered STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 28th. Six research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $275.20.

STERIS Stock Down 0.5%

STE stock opened at $220.01 on Thursday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75. The company’s 50 day simple moving average is $240.19 and its 200-day simple moving average is $248.16. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The firm has a market capitalization of $21.58 billion, a PE ratio of 30.68 and a beta of 1.07.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.STERIS’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were given a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend was Tuesday, February 17th. STERIS’s dividend payout ratio is 35.15%.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.